Tesla Full Self-Driving gets an offer to be insured for ‘almost free’

Recent reports have indicated that Elon Musk’s brain-implant startup, Neuralink, has leased a five-story, 144,000-square-foot building in South San Francisco. At the same time, Musk’s artificial intelligence startup xAI is reportedly also looking around for a Bay Area office. 

The news marks a noticeable step in Musk’s expanding presence in the Bay Area, despite the move of his biggest companies, Tesla and SpaceX, to Texas.

Neuralink’s Bay Area expansion

As noted in a report from the San Francisco Business Times, the property that Neuralink has leased is located at 499 Forbes Boulevard, and it was built by Aralon Properties before it was leased to cancer test developer InterVenn Biosciences. The site, however, had remained vacant since 2023 after InterVenn canceled its 10-year lease.

xAI, Musk’s artificial intelligence startup, is reportedly scouting for an even larger Bay Area office as well, as noted in a report from the San Francisco Chronicle. Combined, the two ventures could secure nearly 400,000 square feet of local workspace, a move seen as a symbolic return of sorts for Musk-led innovation to Silicon Valley.

Neuralink’s momentum

Founded in 2016, Neuralink develops brain-computer interfaces intended to help paralyzed patients control digital devices through thought. The company received U.S. regulatory approval in 2023 to begin human trials, with its first patient, quadriplegic Noland Arbaugh, making headlines for his stunning ability to control a computer cursor and play games using only his mind. Since receiving his implant, Arbaugh has stated that he now browses the web, plays video games like Mario Kart, studies neuroscience, and operates his smart home without lifting a finger. 

Nauralink is only just getting started, with Elon Musk noting on X that the company is busy preparing its next product, Blindsight, for human trials. As per Musk, Neuralink is “aiming to restore (limited) sight to the completely blind next year,” an aggressive target for a potentially life-changing device.